Parkinson's Disease: Causes, Symptoms & Stages

What Is Parkinson's Disease?

Parkinson's disease is a progressive neurodegenerative disorder that primarily affects movement. It occurs when dopamine-producing neurons in the substantia nigra — a region of the brain that controls movement — gradually degenerate and die. Dopamine is a neurotransmitter that transmits signals between nerve cells, and its depletion leads to the characteristic motor symptoms of Parkinson's: tremor, rigidity, slowness of movement (bradykinesia), and postural instability.

Parkinson's is the second most common neurodegenerative disease after Alzheimer's, affecting approximately 1% of people over age 60 and 3% over age 80. While the disease is chronic and progressive, treatments — including Cuba's neurological restoration programs — can significantly improve quality of life and slow the functional decline associated with the condition.

Causes & Risk Factors

The exact cause of Parkinson's disease is not fully understood, but it is believed to result from a combination of genetic and environmental factors:

Genetic factors — About 10-15% of Parkinson's cases have a family history. Mutations in genes such as LRRK2, PARK7, PINK1, PRKN, and SNCA have been linked to familial Parkinson's. However, most cases are sporadic (without a clear genetic cause).

Environmental factors — Exposure to certain toxins (pesticides, herbicides, industrial chemicals), head injuries, and rural living with well water consumption have been associated with increased risk. The link between pesticide exposure and Parkinson's is one of the strongest environmental associations.

Age — Advancing age is the single most significant risk factor. The average age of onset is around 60, though early-onset Parkinson's (before age 50) accounts for about 10-20% of cases.

Gender — Men are approximately 1.5 times more likely to develop Parkinson's than women.

The Five Stages of Parkinson's (Hoehn & Yahr Scale)

Parkinson's progression is commonly classified using the Hoehn and Yahr scale:

Stage 1 — Symptoms are mild and affect one side of the body only (unilateral involvement). Minimal functional impairment. Tremor may appear in one limb. Daily activities are largely unaffected.

Stage 2 — Symptoms affect both sides of the body (bilateral involvement) or the midline (axial). Balance is not yet impaired. Daily activities may take longer but independence is maintained.

Stage 3 — Mild to moderate bilateral disease with some postural instability. The patient is still physically independent in daily activities but may need assistance with certain tasks. This is considered a transitional stage.

Stage 4 — Severe disability. The patient can still walk or stand unassisted but requires substantial help with activities of daily living. Living alone becomes difficult.

Stage 5 — The patient is confined to a wheelchair or bedridden unless assisted. Constant nursing care is required. Standing and walking are possible only with assistance.

Cuba's neurological restoration programs are most effective in Stages 1-3, where neuroprotective therapy and intensive rehabilitation can help preserve function and slow progression. Patients in Stage 4 may also benefit from rehabilitation, though the goals shift toward maintaining quality of life rather than restoring lost function.

When to Seek Neurological Evaluation

Early diagnosis and intervention are critical in Parkinson's disease. If you or a family member experiences any of the following, a neurological evaluation is recommended:

• Resting tremor in one hand (the classic 'pill-rolling' tremor) • Slowness in daily activities (buttoning shirts, brushing teeth) • Stiffness or rigidity in limbs or trunk • Changes in handwriting (smaller, cramped — micrographia) • Reduced facial expression (masked face) • Soft or monotone voice • Stooped posture or balance changes • Loss of sense of smell (often an early pre-motor symptom)

Cuba's International Center for Neurological Restoration (CIREN) offers comprehensive diagnostic evaluations for international patients, including neurological examination, brain imaging, neuropsychological assessment, and personalized treatment planning.